Known targets — ChEMBL curated mechanism
CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D
The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | STAT3 | P40763 | 1/20 | 0.41 |
| ▸ | STAT1 | P42224 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | GLA | P06280 | 2/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzoic Acid SCHEMBL28410519 | 1.00 | DAO (0.48) | DAOTSHRNAPRTALDH1A1KDM4E | |
| Benzoic Acid SCHEMBL4657369 | 1.00 | DAO (0.48) | DAOTSHRNAPRTALDH1A1KDM4E | |
| Benzoic Acid SCHEMBL5161411 | 0.98 | DAO (0.47) | DAOTSHRNAPRTALDH1A1KDM4E | |
| Benzoic Acid SCHEMBL28157733 | 0.98 | DAO (0.47) | DAOTSHRNAPRTALDH1A1KDM4E | |
| Benzoic Acid SCHEMBL1361627 | 0.98 | DAO (0.47) | DAOTSHRNAPRTALDH1A1KDM4E | |
| Benzoic Acid SCHEMBL17687656 | 0.98 | DAO (0.47) | DAOTSHRNAPRTALDH1A1KDM4E | |
| Benzoic Acid SCHEMBL29136455 | 0.98 | DAO (0.47) | DAOTSHRNAPRTALDH1A1KDM4E | |
| Terephthalic Acid SCHEMBL28411701 | 0.93 | TSHR (0.44) | TSHRALDH1A1KDM4EHPGDSRD5A2 | |
| Terephthalic Acid SCHEMBL28411703 | 0.93 | TSHR (0.44) | TSHRALDH1A1KDM4EHPGDSRD5A2 | |
| SCHEMBL29090785 | 0.91 | EGFR (0.49) | ALDH1A1KDM4EHPGDNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2287613-A2 | Detection, monitoring and treatment of cancer | THE OPEN UNIVERSITY (GB) | 2011-02-23 | — | — | EP | disclosed |
| EP-1601970-B1 | DETECTION, MONITORING AND TREATMENT OF CANCER | UNIV OPEN (GB) | 2010-10-27 | — | — | EP | disclosed |
| EP-2209000-A2 | Detection, monitoring and treatment of cancer | THE OPEN UNIVERSITY (GB) | 2010-07-21 | — | — | EP | disclosed |
| US-20070160526-A1 | Detection, monitoring and treatment of cancer | THE OPEN UNIVERSITY (GB) | 2007-07-12 | — | — | US | disclosed |
| EP-1806585-A1 | Detection, monitoring and treatment of cancer | THE OPEN UNIVERSITY (GB) | 2007-07-11 | — | — | EP | disclosed |
| EP-1601970-A2 | DETECTION, MONITORING AND TREATMENT OF CANCER | THE OPEN UNIVERSITY (GB) | 2005-12-07 | — | — | EP | disclosed |
| WO-2004081574-A2 | DETECTION, MONITORING AND TREATMENT OF CANCER | THE OPEN UNIVERSITY (GB) | 2004-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070160526-A1 | Detection, monitoring and treatment of cancer | MUC1, CA14, LGALS4 | DAO 4034/4885TSHR 809/4885NAPRT 2658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.